1994 related items for PubMed ID: 15574639
1. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
[Abstract] [Full Text] [Related]
2. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
[Abstract] [Full Text] [Related]
3. Kawasaki disease.
Kim DS.
Yonsei Med J; 2006 Dec 31; 47(6):759-72. PubMed ID: 17191303
[Abstract] [Full Text] [Related]
4. Kawasaki disease.
Newburger JW, Fulton DR.
Curr Opin Pediatr; 2004 Oct 31; 16(5):508-14. PubMed ID: 15367843
[Abstract] [Full Text] [Related]
5. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 31; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
6. Kawasaki Disease at 50 Years.
Cohen E, Sundel R.
JAMA Pediatr; 2016 Nov 01; 170(11):1093-1099. PubMed ID: 27668809
[Abstract] [Full Text] [Related]
7. Diagnosis and management of kawasaki disease.
Saguil A, Fargo M, Grogan S.
Am Fam Physician; 2015 Mar 15; 91(6):365-71. PubMed ID: 25822554
[Abstract] [Full Text] [Related]
8. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
Kossiva L, Karanassios E, Papadopoulos G, Karavanaki K.
Cardiol Young; 2012 Aug 15; 22(4):461-5. PubMed ID: 21933460
[Abstract] [Full Text] [Related]
9. [Kawasaki disease in children--9 years experience].
Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
Med Wieku Rozwoj; 2005 Aug 15; 9(2):179-93. PubMed ID: 16085959
[Abstract] [Full Text] [Related]
10. Kawasaki disease: summary of the American Heart Association guidelines.
Freeman AF, Shulman ST.
Am Fam Physician; 2006 Oct 01; 74(7):1141-8. PubMed ID: 17039750
[Abstract] [Full Text] [Related]
11. Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.
Sivakumar K, Pavithran S.
Pediatr Cardiol; 2013 Feb 01; 34(2):444-6. PubMed ID: 22427313
[Abstract] [Full Text] [Related]
12. Kawasaki disease: a comprehensive review of treatment options.
Patel RM, Shulman ST.
J Clin Pharm Ther; 2015 Dec 01; 40(6):620-5. PubMed ID: 26547265
[Abstract] [Full Text] [Related]
13. Long-term cardiac sequelae of Kawasaki disease.
Fulton DR, Newburger JW.
Curr Rheumatol Rep; 2000 Aug 01; 2(4):324-9. PubMed ID: 11123078
[Abstract] [Full Text] [Related]
14. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
Williams K.
J Pediatr Health Care; 2017 Aug 01; 31(2):196-202. PubMed ID: 27592169
[Abstract] [Full Text] [Related]
15. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
[Abstract] [Full Text] [Related]
16. Kawasaki disease: Medical therapies.
Newburger JW.
Congenit Heart Dis; 2017 Sep 17; 12(5):641-643. PubMed ID: 28580631
[Abstract] [Full Text] [Related]
17. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
Calabri GB, Falcini F, Favilli S, Pollini I, Capuzzo L, Simonini G, De Simone L.
Pediatr Med Chir; 2002 Sep 17; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
[Abstract] [Full Text] [Related]
18. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W.
Circulation; 1994 Feb 17; 89(2):916-22. PubMed ID: 8313588
[Abstract] [Full Text] [Related]
19. A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disease.
Kahwaji IY, Connuck DM, Tafari N, Dahdah NS.
Pediatr Cardiol; 2002 Feb 17; 23(6):639-46. PubMed ID: 12530498
[Abstract] [Full Text] [Related]
20. Kawasaki Disease: Beyond IVIG and Aspirin.
Moussa T, Wagner-Weiner L.
Pediatr Ann; 2019 Oct 01; 48(10):e400-e405. PubMed ID: 31609999
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
